Will the AI-designed vaccine successfully complete Phase 1 clinical trials by December 31, 2025?

This question assesses the initial safety and efficacy of the 'world-first' AI-designed vaccine. Successful completion means the vaccine passes all primary endpoints of a Phase 1 trial as reported by the developers or a regulatory body.

Implied probability (Yes)

60%

Closes

2026-09-03